SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma.
Saved in:
| Title: | SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. |
|---|---|
| Authors: | Choe JH; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Watchmaker PB; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA., Simic MS; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Gilbert RD; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA., Li AW; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Krasnow NA; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Downey KM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA., Yu W; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Carrera DA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA., Celli A; Department of Veterans' Affairs Medical Center, University of California, San Francisco, San Francisco, CA 94158, USA., Cho J; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Briones JD; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Duecker JM; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA., Goretsky YE; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA., Dannenfelser R; Department of Computer Science, Princeton University, Princeton, NJ 08540, USA.; Center for Computational Biology, Flatiron Institute, New York, NY 10010, USA., Cardarelli L; Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada., Troyanskaya O; Department of Computer Science, Princeton University, Princeton, NJ 08540, USA.; Center for Computational Biology, Flatiron Institute, New York, NY 10010, USA., Sidhu SS; Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada., Roybal KT; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. kole.roybal@ucsf.edu hideho.okada@ucsf.edu wendell.lim@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94158, USA.; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA., Okada H; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA. kole.roybal@ucsf.edu hideho.okada@ucsf.edu wendell.lim@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94158, USA.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA., Lim WA; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. kole.roybal@ucsf.edu hideho.okada@ucsf.edu wendell.lim@ucsf.edu.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.; Howard Hughes Medical Institute, San Francisco, CA 94158, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2021 Apr 28; Vol. 13 (591). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33910979 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Choe+JH%22">Choe JH</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Watchmaker+PB%22">Watchmaker PB</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Simic+MS%22">Simic MS</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+RD%22">Gilbert RD</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Li+AW%22">Li AW</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Krasnow+NA%22">Krasnow NA</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Downey+KM%22">Downey KM</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Yu+W%22">Yu W</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Carrera+DA%22">Carrera DA</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Celli+A%22">Celli A</searchLink>; Department of Veterans' Affairs Medical Center, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Cho+J%22">Cho J</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Briones+JD%22">Briones JD</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Duecker+JM%22">Duecker JM</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Goretsky+YE%22">Goretsky YE</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Dannenfelser+R%22">Dannenfelser R</searchLink>; Department of Computer Science, Princeton University, Princeton, NJ 08540, USA.; Center for Computational Biology, Flatiron Institute, New York, NY 10010, USA.<br /><searchLink fieldCode="AU" term="%22Cardarelli+L%22">Cardarelli L</searchLink>; Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.<br /><searchLink fieldCode="AU" term="%22Troyanskaya+O%22">Troyanskaya O</searchLink>; Department of Computer Science, Princeton University, Princeton, NJ 08540, USA.; Center for Computational Biology, Flatiron Institute, New York, NY 10010, USA.<br /><searchLink fieldCode="AU" term="%22Sidhu+SS%22">Sidhu SS</searchLink>; Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, Ontario M5S 3E1, Canada.<br /><searchLink fieldCode="AU" term="%22Roybal+KT%22">Roybal KT</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. kole.roybal@ucsf.edu hideho.okada@ucsf.edu wendell.lim@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94158, USA.; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Okada+H%22">Okada H</searchLink>; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA 94158, USA. kole.roybal@ucsf.edu hideho.okada@ucsf.edu wendell.lim@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA 94158, USA.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.<br /><searchLink fieldCode="AU" term="%22Lim+WA%22">Lim WA</searchLink>; Cell Design Institute and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. kole.roybal@ucsf.edu hideho.okada@ucsf.edu wendell.lim@ucsf.edu.; Helen Diller Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.; Howard Hughes Medical Institute, San Francisco, CA 94158, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101505086%22">Science translational medicine</searchLink> [Sci Transl Med] 2021 Apr 28; Vol. 13 (591). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101505086 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1946-6242 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219466234%22">19466234 </searchLink><i>NLM ISO Abbreviation: </i>Sci Transl Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33910979 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/scitranslmed.abe7378 Languages: – Code: eng Text: English Titles: – TitleFull: SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Choe JH – PersonEntity: Name: NameFull: Watchmaker PB – PersonEntity: Name: NameFull: Simic MS – PersonEntity: Name: NameFull: Gilbert RD – PersonEntity: Name: NameFull: Li AW – PersonEntity: Name: NameFull: Krasnow NA – PersonEntity: Name: NameFull: Downey KM – PersonEntity: Name: NameFull: Yu W – PersonEntity: Name: NameFull: Carrera DA – PersonEntity: Name: NameFull: Celli A – PersonEntity: Name: NameFull: Cho J – PersonEntity: Name: NameFull: Briones JD – PersonEntity: Name: NameFull: Duecker JM – PersonEntity: Name: NameFull: Goretsky YE – PersonEntity: Name: NameFull: Dannenfelser R – PersonEntity: Name: NameFull: Cardarelli L – PersonEntity: Name: NameFull: Troyanskaya O – PersonEntity: Name: NameFull: Sidhu SS – PersonEntity: Name: NameFull: Roybal KT – PersonEntity: Name: NameFull: Okada H – PersonEntity: Name: NameFull: Lim WA IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 04 Text: 2021 Apr 28 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1946-6242 Numbering: – Type: volume Value: 13 – Type: issue Value: 591 Titles: – TitleFull: Science translational medicine Type: main |
| ResultId | 1 |